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Background: Phenamil (PH) is a small molecule that induces bone formation through
upregulation of the TRB3 gene in the bone-regeneration process. β-Cyclodextrins (βCDs)
with hydrophilic surfaces and a relatively hydrophobic cavity can form inclusion complexes
with primarily hydrophobic small molecules such as PH, and increase their apparent solubility
and dissolution rate. The hydrophilic surface of βCDs prevents their interaction with the
hydrophobic lipids of the cell membrane for penetration. Therefore, binding of penetrative
groups, such as lysine, arginine, and histidine (His), to βCDs for cell penetration is required.
Aim: The aim of this study was to investigate the effect of His-conjugated βCD on cellular
uptake of PH for bone differentiation.
Methods: In this study, His-βCDs were synthesized and used to prepare an inclusion complex
of His-βCD-PH.A hydroxypropyl–βCD-PH (HP-βCD-PH) inclusion complex for increasing PH
solubility without a penetrative group was prepared for comparison. 3-D geometry of βCD
derivatives and PH-inclusion complexes was investigated by Fourier-transform infrared spectro-
scopy and molecular docking. Alizarin red staining and real-time PCR were performed to
compare bone differentiation of His-βCD-PH and HP-βCD-PH.
Results: The results suggested that the benzene ring of PH was inserted into the wide side of
both His-βCD and HP-βCD. Alizarin red staining at 14 days postculture in the presence of
His-βCD-PH at total concentration of 50 μM for PH showed that bone-matrix mineralization
increased significantly compared with free PH and HP-βCD-PH. Real-time PCR confirmed
this result, and showed gene expression increased significantly (OPN 1.84-fold, OCN 1.69-
fold) when stem cells were cultured with His-βCD-PH.
Conclusion: The overall results indicated that His-βCD-PH is a promising carrier for
osteoinductive PH with possible penetration ability and sustained release that reduces
BMP2 consumption for differentiation of mesenchymal stem cells to bone tissue.
Keywords: phenamil, β-cyclodextrin, inclusion complex, histidine, cell penetration, bone
regeneration
Introduction
Growth factors are polypeptides that through binding to cell-membrane receptors and
signal guiding lead to changes in cellular behavior, such as differentiation and prolif-
eration. For example, BMP2 is a growth factor secreted by osteoblasts and plays a key
role in differentiating stem cells for bone regeneration. The use of BMP2 in clinical and
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preclinical studies has been associated with successful bone
formation.1,2 Despite many benefits of BMP2, its widespread
use is limited, due to the complex production process (gene
cloning), high prices, low stability, and side effects when
used in superphysiological concentrations.3,4 As such, there
is a need for an alternative with benefits similar to BMP2 for
stimulating bone differentiation, but with fewer drawbacks.
Low-molecular-weight nonpeptide small molecules with
favorable features, such as high stability and low price,
along with the ability to stimulate bone differentiation have
been intensively studied in recent years.1,2
Phenamil (PH; Figure 1A) is an FDA-approved small
molecule known as an amiloride diuretic drug that leads to
osteogenesis by upregulating TRB3 gene expression in bone
signaling. Moreover, PH enhances the BMP-signaling path-
way by decreasing expression of the SMURF1 protein and
increasing the expression level of SMADs, which are essen-
tial transcriptional factors of the BMP pathway.5–8 It has been
reported that use of PH together with BMP2 could be effec-
tive in reducing the consumption of BMP2, thereby reducing
costs and side effects while achieving the same level of
ossification.5,8,9 Unfortunately, despite all the useful features
of PH, its poor aqueous solubility has limited its widespread
use.8 Furthermore, the positive differentiation effect of PH
and its toxicity have shown that the therapeutic window is
very narrow. In other words, PH is highly effective for bone
formation at concentrations of 10 and 20 µM, but causes cell
death with adverse effects on bone formation at higher
concentrations.10,11 Therefore, sustained delivery of PH
within the desirable concentration range for bone formation
is much required.
Cyclodextrins (CDs) are FDA-approved cyclic oligosac-
charides with a hydrophilic outer surface and internal hydro-
phobic cavity that can form inclusion complexes with many
hydrophobic molecules.12,13 It has been proven that inclusion
complexes of CDs have the potential to increase the apparent
solubility and bioavailability of many drugs.14–16 Among
natural CDs, βCD (Figure 1B) is the most popular, because
of its suitable cavity size for trapping many hydrophobic
molecules.14 Inclusion-complex formation with hydrophobic
molecules not only increases their apparent solubility with
reduced use of toxic solvents but also leads to sustained
release of hydrophobic molecules with no burst effect. In
aqueous solution, there is a dynamic equilibrium between the
drug in the inclusion complex and free drug that is constantly
being formed and dissociated.17 Despite these benefits, non-
invasive transfer of biomolecules like CDs through the cell
membrane is restricted, due to their hydrophilic surface.18 As
such, to increase cellular uptake, CDs need to be modified to
facilitate cell penetration.
Figure 1 Chemical structure of A) PH; B) βCD.
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The cell membrane is composed primarily of anionic
carbohydrates and lipids. Therefore, cationic molecules
can interact electrostatically with the cell membrane and
enter the cytoplasm through endocytosis or direct translo-
cation. Lysine, arginine, and histidine (His) are cationic
amino acids, among which His is a pH-sensitive amino
acid with a higher positive charge than lysine and arginine
at low pH.19 The existence of a pH-sensitive domain on
biomolecules helps their easy escape from endocytosis
vesicles. Researchers have suggested a mechanism based
on the His domain absorbs the proton’s endosomal layer
and results in increased osmotic pressure in the endosomal
vesicle, endosomal membrane rupture, and consequent
release of molecules in the cytoplasm (proton-sponge
effect).18,20 In one study, two groups of βCD derivatives
(βCD-amine and βCD-His) were compared in terms of cell
permeability. It was proved that His groups increased the
penetration of CD into cells rather than amine groups.21 In
other studies, biomolecules attached to the His-rich chain
for gene transfer exhibited high transfection efficiency22
and functionalized αCD with His resulted in increased
gene-transfer rates than non-His groups.23
The purpose of the present study was to investigate the
induction efficiency of His-conjugated βCD-PH inclusion
complexes on bone differentiation. Selective cationic His-
functionalized βCD (His-βCD)was synthesized as a cell-pene-
tration enhancer, and its effect on the solubility of PH was
investigated in an aqueous medium. Then, inclusion com-
plexes of His-βCD-PH and highly soluble hydroxypropyl–
βCD-PH (HP-βCD-PH) were prepared and mesenchymal
stem cell (MSC) differentiation from bone tissue in the pre-
sence of these inclusion complexes and BMP2 compared with
that of free PH.Molecular dynamicswere assessed to elucidate
the 3-D geometry of the inclusion complexes.
Methods
Materials
βCD and HP-βCD (molecular weight 1,541.6 Da) were
obtained from Wacker (Burghausen, Germany). Boc-His-
OH, PH methanesulfonate, and all chemicals used for
synthesis of βCD derivatives were purchased from
Sigma-Aldrich. BMP2 growth factor was obtained from
Thermo Fisher Scientific.
His-βCD Synthesis
To prepare His-βCD, a previous method with a few mod-
ifications was used.24 Figure 2 shows the synthesis proce-
dure and structure of His-βCD. According to the procedure
for selective His binding to 6-OH of βCD, at first 6-deoxy-
amine-βCD (amine-βCD) was prepared. After attaching
amine to the 6-OH, a covalent bond between the amine
group from amine-βCD and the carboxyl group of His was
established. For His-βCD preparation, a covalent bond of
phenylalanine to amine-βCD was inspired.25 Briefly, 66 mg
Boc-His-OH (0.2 mmoL) and 80 mg N-hydroxybenzotria-
zole (0.4 mmol) were dissolved in 5 mL anhydrous N,N-
dimethylformamide. Then, the solution was cooled to 0°C
and 100 mg N,N-dicyclohexylcarbodiimide (0.4 mmol) was
Figure 2 Schematic of His-βCD preparation.
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added and stirred at 0°C for 1 hour (400 rpm), followed by
4 hours (400 rpm) at room temperature to precipitate the by-
product dicyclourea. Then, 260 mg 6-deoxy-amine-βCD
and 120 µL ethylmorpholine suspension in 5 mL dimethyl-
formamide were added to the reaction mixture and stirred at
40°C without a cap overnight. To ensure the end of the
reaction, thin-layer chromatography (TLC) plates were pre-
pared after 3, 5, and 7 hours. Then, dicyclohexylurea was
filtered off to obtain oil-like liquid under reduced pressure
and 50 mL acetone was added for product precipitation. The
precipitate was washed with acetone twice and dried under
high vacuum to obtain off-white powder (0.285 g, 87%). To
remove the Boc group, the obtained powder was first dis-
solved in 2 mL trifluoroacetic acid and stirred. After 1 hour,
to remove the acid, the resulting solution was washed with
methanol several times, followed by solvent removal with a
rotary evaporator and then freeze-dried to obtain the final
product, which was characterized by 1H nuclear magnetic
resonance (NMR) and Fourier-transform infrared (FTIR)
spectroscopy.
Characterization
Fourier-Transform Infrared Spectroscopy
FTIR spectra of all samples were recorded using FTIR
spectrometry (Tensor II) equipped with a diamond attenu-
ated total reflection (ATR) accessory. All transmittance
spectra were generated by placing specific amounts of
powder (air background) or liquid drops (liquid back-
ground) on the tip of the ATR. Data were obtained
between 4,000 cm−1 and 500 cm−1 at 4 cm−1 scanning
speed with 64 scans.
Hydrogen Nuclear Magnetic Resonance Analysis
All NMR spectra to characterize selective reaction of pri-
mary alcohol were recorded in DMSO-d6 and the rest
recorded in D2O using a Bruker Avance DRX 600 MHz.
Parameters used during the NMR experiments were number
of scans (32), relaxation delay (1 seconds) and pulse tem-
perature (25°C).
Dynamic Light Scattering And ζ-Potential
Dynamic light scattering (DLS) and ζ-potential of βCD
derivatives with fixed concentrations at two pH values of
4.5 (related to early and late endosomes using 2-(N-mor-
pholino)ethanesulfonic acid buffer) and 7.1 (related to cell
environment using PBS) were measured with a particle-
size analyzer (Malvern Zetasizer Nano ZS2000) based on
quasielastic light scattering. Briefly, human adipose-
derived SCs (hASCs) were cultured (passage 5) and then
separated from the bottom of the plate, followed by cen-
trifugation. Then, the supernatant was removed, followed
by addition of 1 mL PBS and ζ-potential was recorded
immediately.
His-βCD-PH And HP-βCD-PH Inclusion-
Complex Preparation
PH (1 mg) was added to aqueous solution containing
various concentrations (0–10 mM) of βCD derivatives
(His-βCD and HP-βCD) separately. The mixture was stir-
red for 48 hours to reach equilibrium at 37°C. After that,
the mixture was centrifuged for 10 minutes at 3,000 rpm
and the resulting supernatant was filtered with a 0.45 µm
Phenex-RC (Phenomenex). Solid phases (undissolved PH)
were collected and dried in an oven at 35°C for 2 days.
[PH]T was obtained by ultraviolet absorbance at 289 and
365 nm with ultraviolet spectrophotometry. Also, HPLC
(Kinetex C18 column, 150×4.6 mm, 5 µm; Alltech) analy-
sis was performed to measure the amount of CD deriva-
tives and inclusion-complex components.
Molecular Docking
Molecular docking was performed to elucidate the 3-D
geometry of βCD derivatives and PH inclusion complex
in aqueous medium using Schrödinger 2018 software. An
amber force field was used in Polak–Ribière conjugate
gradient–energy minimization of βCD derivatives and
PH. Docking using Maestro Glide 11.8 was performed
with the centroid of βCD derivatives to center the enclos-
ing box as docking space. Glide score (Gscore) and the
most probable complexation for one minimized structure
of βCD derivatives and PH, assuming 1:1 interaction, were
recorded to compare the binding affinity of PH with the
βCD derivatives.
Cell Culture
hASCs were isolated from adipose tissue of a patient
undergoing elective liposuction following the established
procedure in the literature.26 Cells were cultured in growth
and proliferation αMEM (Sigma-Aldrich) supplemented
with 10% FBS, 1% penicillin–streptomycin (100 U/mL),
and 1% glutamic acid and incubated in a humidified 5%
CO2 atmosphere at 37°C. The cells were used for further
experiments at passage 3.
Jahed et al Dovepress
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Cell-Cytotoxicity Assays
The viability of hASCs (at passages 5–6) was determined
using MTT assays. Briefly, SCs were plated at a density of
8×103 cells/well and incubated for 24 hours. Then, the
medium was exchanged with test solutions of PH at dif-
ferent concentrations (10, 20, 30, 40, and 50 µM) as well
as βCD derivatives in the presence and absence of PH at
specific concentrations (βCD-derivative concentrations
were calculated from HPLC). After 24 hours, MTT solu-
tion (12 mM in PBS) was prepared and diluted (1:5) with
fresh αMEM without FBS, added to each well, and then
incubated for 3 hours at 37°C. After incubation, 100 µL
DMSO was added to each well to dissolve formazan
crystals, and then absorbance was recorded at 570 nm.
The results were compared with those of untreated cells
to obtain cell viability.
Alizarin Red Staining
Alizarin red staining was performed to determine calcium
deposition. Osteogenic differentiation medium supplemen-
ted with 0.05 mM L-ascorbic acid (Sigma-Aldrich), 10 mM
glycerolphosphate disodium (Sigma-Aldrich), 100 nM dex-
amethasone (Sigma-Aldrich), and BMP2 (100 ng) was used
to culture hASCs in the presence of test solutions. After 14
days, cells were fixed in 4% paraformaldehyde for 10
minutes and then washed with PBS twice and incubated
in 2% Alizarin red stain solution for 5 minutes at 25°C.
After that, all wells were washed gently five to six times
with Milli-Q water to remove excess staining agent.
Calcium-deposition images on the plate were taken and
then red-stained samples were observed with an Olympus
BX51 microscope. Also, quantitative calcium levels were
determined using a previously established method.27
Real-Time Polymerase Chain Reaction
hASCs were seeded on a 12-well plate at a density of 2×105
cells/well and incubated overnight. Cells were cultured for
14 days in osteogenic differentiation medium including test
solution, and the medium was exchanged twice with a fresh
one after 5 and 10 days. Then, total RNAwas isolated with
an RNeasy minikit (Bio-Rad) according to the manufac-
turer’s protocol. Then, cDNA was synthesized from
extracted RNA using an iScript advanced cDNA-synthesis
kit (Bio-Rad). All primers used were produced by DNA
Technology (Aarhus, Denmark). The total volume of each
sample was 20 μL, and samples were analyzed in duplicate
with a MyCycler real-time PCR system (Bio-Rad). The
thermocycling program consisted of an initial step of 3
minutes at 95°C and 40 cycles of 15 seconds at 95°C and
an annealing/extension temperature of 60°C for 30 seconds.
Sequences of the primer sets were:
Osteocalcin (OCN) forward 5ʹ-GAG CCC CAG TCC
CCT ACC C-3ʹ, reverse 5ʹ-GCC TCC TGA AAG CCG
ATG TG-3ʹ
Osteopontin (OPN) forward 5ʹ-TGA TGG CCG AGG
TGATAG TGT GGT-3ʹ, reverse 5ʹ-CCT GGG CAA CGG
GGA TGG-3ʹ
Peptidylprolyl isomerase A (PPIA) forward 5ʹ-TCC
TGG CAT CTT GTC CAT G-3ʹ, reverse 5ʹ-CCA TCC
AAC CAC TCA GTC TTG-3ʹ.
Fold-change gene-expression levels were recorded
using the ΔΔCt method, in which the data were normalized
with the expression level of PPIA.
Statistical Analysis
Data were analyzed with ANOVA followed by Tukey–
Kramer multiple-comparison tests using GraphPad Prism
version 8.00 (GraphPad Software). P<0.05 was statisti-
cally significant. Values are expressed as means± SD.
Results And Discussion
Synthesis And Characterization Of His-
βCD
One of the main goals of this study was the attachment of
His penetrative group to the primary 6-OH of βCD,
located on the primary side of βCD, allowing small mole-
cules to enter the cavity of the βCD from the wider rim.
Primary 6-OH of βCD functionalized with the amine
group (amine-βCD) was prepared and then reacted with
the carboxylic acid groups of His. All spectra assigned to
amine-βCD synthesis from βCD were carried out in
DMSO-d6 to evaluate the selective reaction on the primary
6-OH of βCD. The results showed (Figure S1) that the H1
(4.9 ppm) integration ratio to the secondary hydroxyl
peaks (5.2 and 5.3 ppm) was constant (1:2) during the
synthesis process from βCD to amine-βCD, while the H1
ratio to the primary hydroxyl (4.2 ppm) changed.
Therefore, it was proven that only the primary hydroxyl
was functionalized with the amine group. Also, FTIR was
performed to confirm the formation of the amine group.
Figure 3A shows that the stretching peak at 2,110 cm−1
attributed to the azide group in the azide-βCD spectrum
disappeared when the azide group was converted to an
amine group with a peak at 1,656 cm−1 in the amine-
Dovepress Jahed et al
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βCD spectrum. After binding of the amine group to βCD
had been ensured, His-βCD was characterized by TLC, 1H
NMR, and FTIR analysis. TLC plates (Figure S2) showed
that after 3 and 5 hours of reaction, amine-βCD reactant
was still presented while it had completely reacted with
His after 7 hours. FTIR spectra in Figure 3B show that the
strong peak at 1,702 cm−1, assigned to the C=O stretching
of His, was present in the physical mixture but disap-
peared, and a new peak of covalent amide bond appeared
at 1,668 cm−1. As shown by 1H NMR spectra in Figure 4,
three strong peaks of 7.26–8.6 ppm related to the imida-
zole ring of His appeared after its binding to amine-βCD.
Also, FTIR spectra of Boc deprotection (Figure S3) indi-
cated that the Boc group peak at 1,783 cm−1 had comple-
tely disappeared, and the presence of the free amine group
and the imidazole ring of His confirmed His-βCD
synthesis.
Inclusion-Complex Characterization
Higuchi and Connors presented equations based on CD
solution and the amount of soluble drug from which the
stability constant could be achieved.28 The stability con-
stant of βCD derivatives and PH inclusion complex repre-
sents a dynamic equilibrium between free PH and its
complexed form. The linear stability constant (K1:1)
between βCD derivatives and PH was calculated by
Equation 3, which was derived from Equations 1 and 2:
PH½  þ CD½  Ð ½PH  CD (1)
½PHT ¼ ½PHFree þ PH  CD½  (2)
K1:1 ¼ SS0 1 Sð Þ ¼
PH  CD½ 
PH½  CD½  ¼
½PHT½PHFree
½PHFree CD½ 
(3)
where S and S0 are slope of the phase-solubility diagram
and the solubility of PH in the absence of βCD derivatives,
respectively. [PH]free is the concentration of PH in the free
state, and [PH]T refers to the total concentration of PH in
the solution.
To obtain the stability constant (K1:1) while assuming
1:1 βCD derivatives and PH inclusion–complex formation,
the slope of the phase-solubility diagrams was obtained
using Equation 3. As shown in Figure 5, the His-βCD-PH
inclusion complex had a lower phase solubility–diagram
slope than HP-βCD-PH, revealing that less HP-βCD was
required to dissolve the same concentration of PH. This
result revealed an AL-type phase diagram for both βCD
derivatives as well as His-βCD that could increase the
solubility of PH in aqueous media linearly within the
concentration range studied, but it proved less effective
compared to HP-βCD. The apparent K1:1 value of PH with
HP-βCD and His-βCD was estimated to be 1.6×103 M−1
and 7.29×102 M−1, respectively. In aqueous solution (eg,
associated with the studied cell culture), a dynamic equili-
brium between the free small molecules and the inclusion
complex is established. This balance is substituted with a
competitive displacement due to absorption of a drug by
tissue, causing small molecules to release gradually.29 In
cell-culture medium, the small molecules are absorbed by
the cells as a signal to change a dynamic balance, as long
as all the small molecules in the inclusion complex are
released as free components to be consumed by cells.
Figure 3 FTIR spectra of A) intermediates during Amine-βCD, and B) His-βCD preparation.
Jahed et al Dovepress
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As mentioned, 50 μM PH in DMSO was toxic and had
a negative effect on bone formation. [PH]Free in His-βCD-
PH and HP-βCD-PH inclusion complexes with 50 µM
[PH]T, calculated by Equation 3, was 20.3 and 21.82 μM,
respectively. In other words, the PH available in inclusion
complexes was not released as long as free PH was con-
sumed by MSCs. In these conditions, PH from His-βCD-
PH and HP-βCD-PH inclusion complexes with 50 μM
Figure 4 H NMR spectra of A) Amine-βCD, B) His-βCD in D2O.
Figure 5 Phase solubility diagram of βCD derivatives and PH at 37 ◦C. Data are expressed as the mean ± S.D. (n = 3).
Dovepress Jahed et al
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concentration was released gradually and allowed MSCs
in the culture medium to be exposed to free PH with
optimal concentration during differentiation to bone tissue.
Inclusion-complex formation was confirmed by FTIR.
As shown in Figures 6, there were strong stretching vibra-
tion peaks related to the benzene ring attached to NH2 of
PH in the range of 1,300–1,450 cm−1 and another peak at
2,992 cm−1 assigned to the imidazole ring. When the
inclusion complexes of His-βCD-PH and HP-βCD-PH
were formed, the benzene-ring peak disappeared, while
the imidazole ring peak remained (peak overlapping was
seen in His-βCD between amide bond and C=O stretching
peak of PH, marked by circle). This result indicated that
the main reason for poor solubility of PH was the benzene
ring completely disappeared after inclusion-complex for-
mation. Moreover, 1H NMR analysis was performed in
D2O to verify the presence of PH in inclusion complexes.
The weak peaks in the range of 7–8 that corresponded to
the benzene ring of PH proved the presence of PH
(Figure S4).
The size-distribution results of His-βCD-PH and HP-
βCD-PH obtained by DLS are shown in Table 1. The size
and polydispersity index of His-βCD-PH were less than
those of HP-βCD-PH. ζ-Potential was also obtained to
determine inclusion-complex surface charge and their
potential interaction with negatively charged cell mem-
brane. It should be noted that PH itself has a positive
charge due to amine groups. The results in Table 1 show
that the His-βCD-PH inclusion complex had a positive
surface charge, while HP-βCD-PH was negative. This
experiment was carried out at pH 4.5 (endosomal pH).
The surface charge of His-βCD-PH was more positive
with respect to its charge at pH 7.1, but surface charge
of HP-βCD-PH was more negative. In a previous study,
DLS analysis of histidinylated βCD showed narrow dis-
tribution and good stability at low concentration. The high
positive charge of nanoparticles was also introduced as a
reason for repulsion between the particles, as well as their
stability in solution.21 As a general consequence, the nar-
row size distribution of His-βCD-PH inclusion complex
was due to repulsion of positively charged particles that
reduced their aggregation, while HP-βCD-PH inclusion
complexes tended to aggregate. On the other hand, the
positive surface charge of His-βCD-PH may facilitate its
electrostatic interaction with negatively charged cell mem-
brane, as well as penetration into cells, with consequent
rupture of the endosomal layer due to more positive charge
at endosomal pH. Also, the negatively charged surface of
Figure 6 FTIR spectra of A) His-βCD-PH, and B) HP-βCD-PH inclusion complex.
Table 1 Size Distribution And ζ-potential Of PH Formulated With βCD Derivatives And hASCs
Size Distribution
(nm)
Polydispersity
Index
ζ-Potential
(pH 7.1)
ζ-Potential
(pH 4.5)
His-βCD-PH 137±11 0.21 25±5 44±2
HP-βCD-PH 220±44 0.43 −10±3 −22±2
hASCs in culture medium — — −10±5 —
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HP-βCD-PH inclusion complex cannot overcome the
endosomal layer and escape by exocytosis, even if it enters
the cell membrane through endocytosis.
Molecular docking on inclusion complexes between
βCD derivatives and PH was performed to support phase
solubility–diagram results. As shown in Figure 7, the
benzene ring of PH was inserted into the βCD cavity in
both His-βCD-PH and HP-βCD-PH. On the other hand,
the lower Gscore (an empirical measure of how well a
ligand fits in the binding pocket) showed stronger insertion
of ligands to the CD.30,31 Gscores observed for PH binding
with His-βCD and HP-βCD were −3.085 and −3.704 kJ
mol−1, respectively. This result confirmed the phase-solu-
bility diagram and a higher affinity for PH binding to HP-
βCD compared with His-βCD-PH.
Cell Treatment
As an osteoinductive agent, PH has optimal concentration
where it has the lowest cytotoxicity on MSCs. To evaluate
the optimal concentration of PH with the most positive
effect on hASCs, MTT assays were run after 24 hours of
incubation. As shown in Figure 8A, cell cytotoxicity
increased with increased drug concentration dissolved in
DMSO from 10 to 50 μM, and cell viability decreased to
<80% at concentrations >20 µM. In this study, the
optimum concentration of PH as an osteoinductive small
molecule was 20 μM. As mentioned in the introduction,
the suitable concentration has also been determined to be
20 μM. In previous studies, it was reported that PH at a
concentration of 50 μM was toxic for MSCs, with adverse
effects on bone formation,10,11 which was confirmed in
this study. Figure 8B shows that toxicity of βCD deriva-
tives on hASCs was not significant and cell viability
>90%. Moreover, the viability of hASCs treated with PH
formulated using βCD derivatives at total concentration of
50 μM PH after 24 hours was investigated. In both cases
(His-βCD-PH and HP-βCD-PH), significant toxicity was
not observed at total concentration of 50 µM PH, which
was probably due to the equilibrium between PH in the
inclusion complex and the surrounding culture medium
with a concentration close to optimal value.
Osteogenesis
Extracellular matrix mineralization and quantitative cal-
cium-level deposition were determined at 14 days postcul-
ture by Alizarin red staining. As shown in Figure 9A, in the
presence of His-βCD-PH and HP-βCD-PH, matrix miner-
alization was increased clearly compared with the control.
Free PH in DMSO at a concentration of 20 μMwas selected
as a control, since it induced the most positive osteogenesis
Figure 7 Molecular docking of βCD derivatives and PH inclusion complex. A) His-βCD-PH (B: top view) and C) HP-βCD-PH (D: top view). Mono and random
substitutions were designed for docking map based on 1H NMR and mass spectrometry for His-βCD and HP-βCD, respectively (Data are not shown here).
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effect for bone regeneration in a previous study.5 It is
postulated that sustained release of PH as a result of the
equilibrium between PH in inclusion complexes of βCD
derivatives and PH in cell-culture medium during differen-
tiation had a significant positive effect on matrix minerali-
zation. There was a difference between His-βCD-PH and
HP-βCD-PH for matrix mineralization. Bone-matrix
mineralization in the presence of His-βCD-PH was higher
than that for HP-βCD-PH (Figure 9B). As shown in this
figure, calcium-level deposition was significantly increased
when hASCs were cultured with His-βCD-PH and HP-
βCD-PH at 50 μMconcentration compared with the control.
The results indicated that in addition to increased solubility
of PH by inclusion-complex formation, His conjugation as a
Figure 8 Cell viability of A) PH in DMSO at different concentrations, B) βCD derivatives and corresponding inclusion complexes with PH after 24 hours. The [PH]T and
[CD]T concentrations are shown below the diagram. Data are expressed as the mean ± S.D. (n = 3).
Figure 9 Alizarin-red assay to bone matrix mineralization. A) Staining (Scale bar: 100 μm), and B) Quantitative calcium level deposition. Data are expressed as the mean ±
S.D (n = 3). *p< 0.05, **p < 0.001).
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penetrative group contributed to increased bone mineraliza-
tion. Electrostatic internalization of the His-βCD-PH inclu-
sion complex by MSC membranes and their postendosomal
escape followed by penetration into the nucleus might lead
to better transfer of PH with consequent increase in bone-
matrix mineralization. For detailed investigation on the
effect of His-βCD-PH and HP-βCD-PH on hASCs for
bone differentiation, real-time PCR was performed at 14
days postculture to investigate late bone-marker gene (OCN
andOPN) expression. Figure 10 shows that gene expression
increased significantly (OPN 1.84-fold, OCN 1.69-fold)
when SCs were cultured with His-βCD-PH, but there was
no significant change when they were cultured with HP-
βCD-PH. This result revealed that HP-βCD could increase
the solubility of PH, but it did not have a significant positive
effect on delay in marker-gene expression, even though the
total concentration of PH (not free PH) in the medium
culture was higher than that of the control group.
Generally, PH as a hydrophobic small molecule has good
permeability through the hydrophobic cell membrane,
while its cell permeability decreases when present in inclu-
sion complexes. In addition, aggregation of HP-βCD at high
concentrations may have prevented high transfection of PH
into the nucleus compared with free PH (Figure 11).
Therefore, the only advantage of HP-βCD is to load PH
with sustained-release ability to avoid the toxic effect of PH
at concentrations >20 μM. In a similar study, gene expres-
sion of HP-βCD and a random methyl-βCD (RM-βCD)
inclusion complex with simvastatin (SV) as an osteoinduc-
tive agent (at tenfold concentration compared with free SV)
was investigated. Results showed that the RM-βCD-SV
inclusion complex increased ALP production and bone
delay marker–gene expression significantly compared
with HP-βCD-SV and free SV, while HP-βCD-SV did not
show a significant difference from SV for osteogenesis.
This difference was not explained, but RM-βCD-SV inter-
nalization was attributed to the hydrophobic methyl group
of this complex.32 Therefore, penetration of βCD-derivative
inclusion complexes into cells with increased solubility of
poorly soluble osteoinductive agents was considered
responsible for the higher degree of differentiation of
hASCs compared with the free agent. In another study,
two nonglycerol-based histidylated cationic amphiphiles
with only a single His head group were synthesized as a
nonviral gene-transfection vector. The results showed that
the carrier with a single His penetrative domain could
transfer the gene to the nucleus properly and disturb the
endosomal layer.33
BMP2 is an expensive osteoinductive growth factor
compared with small molecules. To investigate the
effect of PH on reducing BMP2 consumption, alizarin
red staining was performed after 14 days of culture in
osteogenic medium. A control group at a concentration
of 20 μM free PH in DMSO and inclusion complex of
His-βCD-PH at a total concentration of 50 μM ([PH]T)
containing [PH]free close to 20 µM with different
amounts of BMP2 were used in culture medium. As
shown in Figure 12, when BMP2 was reduced by half,
bone-matrix mineralization in both groups decreased
significantly, but the extent of such decrease for the
Figure 10 Real-Time PCR to determine gene expression of bone delay markers. Control: PH at concentration of 20 μM in DMSO; PH in HP-βCD-PH and His-βCD-PH
inclusion complexes at total concentration of 50 μM. Data are expressed as the mean ± S.D. (n = 3). **p < 0.001.
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inclusion complex of His-βCD-PH was less than that
of free PH at a concentration of 20 μM. We suggest
that sustained release of PH from the inclusion com-
plex of His-βCD-PH to culture medium helped to
compensate the reduced amount of BMP2 consumption
for differentiation of hASCs to bone tissue.
Conclusion
Smallmolecules are important agents for differentiation of SCs
because of their lower price and easier preparationwith respect
to growth factors. The main problem is their hydrophobic
structure, which requires the use of toxic solvents, such as
DMSO. Furthermore, most small molecules have an optimal
Figure 11 Conceptual description of His-βCD-PH and HP-βCD-PH inclusion complexes transmittance across cell membrane. HP-βCD-PH aggregates constantly in cell
culture and releases PH into cell membrane slowly but His-βCD-PH probably can penetrate into the cell membrane because of cationic amine group and hydrophobic affinity
and release PH into cytoplasm and nucleus.
Figure 12 The effect of His-βCD-PH inclusion complex and reduced BMP consumption on bone matrix mineralization obtained by Alizarin-red staining. Scale bar: 100 μm.
Data are expressed as the mean ± S.D. (n = 3).
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concentration at which they are most effective for cell differ-
entiation with least cytotoxicity. The sustained release of small
molecules at higher concentrations from suitable carriers pro-
vides desirable concentrations during the differentiation pro-
cess. It iswell established that βCDderivatives can increase the
apparent solubility of small hydrophobicmolecules and release
them more slowly. In this study, inclusion complexes of His-
βCD and PH as an osteoinductive agent at high concentrations
were prepared. Conjugation of His to these inclusion com-
plexes was also investigated. His-βCD not only increased the
solubility of PH but also probably provided cell penetration
and rupture of the endosomal layer with consequent transfer of
PH to the nucleus for cell differentiation. The potential for
sustained release of osteoinductive agents together with possi-
ble cell penetration makes this carrier very promising in bone
tissue–engineering applications.
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